CD4 and diabetes mellitus: To test this assumption, we performed adoptive transfers of effector CD4+CD62L T cells together with CD11b+ bone marrow cells from HDC-deficient or WT mice to NOD RAG−/− recipients, which did not alter diabetes onset (Figure 2(d)), ruling out the increase of IMCs as a cause for diabetes progression.